2-74502817-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000460508.3(LBX2):āc.43G>Cā(p.Gly15Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000306 in 1,613,740 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000460508.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LBX2 | NM_001009812.2 | c.43G>C | p.Gly15Arg | missense_variant | 1/2 | NP_001009812.1 | ||
LBX2-AS1 | NR_024606.2 | n.225C>G | non_coding_transcript_exon_variant | 1/1 | ||||
LBX2-AS1 | NR_152616.1 | n.225C>G | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LBX2 | ENST00000460508.3 | c.43G>C | p.Gly15Arg | missense_variant | 1/2 | 1 | ENSP00000417116.2 | |||
LBX2 | ENST00000550249.2 | n.381+19G>C | intron_variant | 1 | ||||||
LBX2 | ENST00000341396.2 | c.24+19G>C | intron_variant | 3 | ENSP00000450229.1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000172 AC: 43AN: 249400Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135038
GnomAD4 exome AF: 0.000310 AC: 453AN: 1461424Hom.: 1 Cov.: 31 AF XY: 0.000316 AC XY: 230AN XY: 726932
GnomAD4 genome AF: 0.000269 AC: 41AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.43G>C (p.G15R) alteration is located in exon 1 (coding exon 1) of the LBX2 gene. This alteration results from a G to C substitution at nucleotide position 43, causing the glycine (G) at amino acid position 15 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at